SCI Pharmtech Inc
TWSE:4119
SCI Pharmtech Inc
Other Long-Term Assets
SCI Pharmtech Inc
Other Long-Term Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
S
|
SCI Pharmtech Inc
TWSE:4119
|
Other Long-Term Assets
NT$233.9m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
24%
|
CAGR 10-Years
14%
|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Other Long-Term Assets
NT$378.3m
|
CAGR 3-Years
16%
|
CAGR 5-Years
19%
|
CAGR 10-Years
7%
|
|
![]() |
Formosa Laboratories Inc
TWSE:4746
|
Other Long-Term Assets
NT$98.3m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
6%
|
|
![]() |
ScinoPharm Taiwan Ltd
TWSE:1789
|
Other Long-Term Assets
NT$640m
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
3%
|
|
![]() |
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Other Long-Term Assets
NT$655.2m
|
CAGR 3-Years
10%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-7%
|
|
![]() |
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Other Long-Term Assets
NT$209m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
SCI Pharmtech Inc
Glance View
SCI Pharmtech Corp. is engaged in the biotechnology and medical care industry. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2002-08-12. The firm's main products include APIs, API intermediates and special and precision chemicals. The firm distributes its products in domestic market and to overseas markets, including Europe, the Americas, the rest areas of Asia and others
See Also
What is SCI Pharmtech Inc's Other Long-Term Assets?
Other Long-Term Assets
233.9m
TWD
Based on the financial report for Dec 31, 2024, SCI Pharmtech Inc's Other Long-Term Assets amounts to 233.9m TWD.
What is SCI Pharmtech Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
14%
Over the last year, the Other Long-Term Assets growth was -25%. The average annual Other Long-Term Assets growth rates for SCI Pharmtech Inc have been -23% over the past three years , 24% over the past five years , and 14% over the past ten years .